Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Ketamine for Rett Syndrome
NCT03633058Phase 2Completed
- Sponsor
- Rett Syndrome Research Trust
- Start
- Mar 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in Rett syndrome (RTT), sponsored by Rett Syndrome Research Trust. Started Mar 2019; status: completed.
02
Drugs
ketamine
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on NCT03633058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03633058.